Transfusion-associated adverse reactions (TAARs) and cytokine accumulations in the stored blood components: the impact of prestorage versus poststorage leukoreduction.

about

Transfusion-associated adverse reactions (TAARs) and cytokine accumulations in the stored blood components: the impact of prestorage versus poststorage leukoreduction.

Item

http://www.wikidata.org/entity/Q50053079

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Transfusion-associated adverse ...... us poststorage leukoreduction.

@en

Transfusion-associated adverse reactions

@nl

type

Item

label

Transfusion-associated adverse ...... us poststorage leukoreduction.

@en

Transfusion-associated adverse reactions

@nl

prefLabel

Transfusion-associated adverse ...... us poststorage leukoreduction.

@en

Transfusion-associated adverse reactions

@nl

P1476

Transfusion-associated adverse ...... us poststorage leukoreduction.

@en

P2093

Chih-Chun Chang

http://www.w3.org/2001/XMLSchema#string

Fang-Yeh Chu

http://www.w3.org/2001/XMLSchema#string

Fang-Yi Cheng

http://www.w3.org/2001/XMLSchema#string

Hsiu-Chen Lin

http://www.w3.org/2001/XMLSchema#string

Ming-Jang Su

http://www.w3.org/2001/XMLSchema#string

Tai-Chen Lee

http://www.w3.org/2001/XMLSchema#string

Tzung-Hai Yen

http://www.w3.org/2001/XMLSchema#string

Yi-Ting Chen

http://www.w3.org/2001/XMLSchema#string

P2860

OX40 ligand regulates inflammation and mortality in the innate immune response to sepsis

The role of the plasma from platelet concentrates in transfusion reactions.

An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusions.

Universal leukoreduction of cellular blood components in 2001? Yes.

Non-infectious complications of transfusion therapy.

The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC.

The intention-to-treat principle in clinical trials and meta-analyses of leukoreduced blood transfusions in surgical patients.

Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis.

Leukocyte reduction's role in the attenuation of infection risks among transfusion recipients.

Leukocyte depletion for safe blood transfusion.

P304

4385-4394

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.23136

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29435110

http://www.w3.org/2001/XMLSchema#string

P932

5796981

http://www.w3.org/2001/XMLSchema#string